Doctor may soon determine who needs a colonoscopy
A university researchers are developing a simple blood test that can helps doctor determine who needs a colonoscopy, a screening procedure for colon cancer recommended for all adults over fifty years of ages but one considered so unlpeasant that many avoid. The new test, which looks for cancer related proteins in the blood, identifies colon cancer and precancerous polyps almost as well as a colonoscopy, according to a study published in the journal cancer reserved.
The reservers say their test won't replace colonoscopies but might provide a non-invasive means of identifying high risk patients and incentive for them to undergo the more invasive procedure. What their are trying to do is to to used blood markers for cancer like they are doing for cholesterol levels to predict heart disease risk.
The reservers say their test won't replace colonoscopies but might provide a non-invasive means of identifying high risk patients and incentive for them to undergo the more invasive procedure. What their are trying to do is to to used blood markers for cancer like they are doing for cholesterol levels to predict heart disease risk.
Labels: symptoms of ovarian cancer
Comments:
<< Home
http://ovariancancerdebate.blogspot.com/
Survivors' Debate: The Past Decade in Ovarian Cancer
Two Countries-Two Debates: Patient-led/funded:
Ovarian cancer survivors, Carolyn Benivegna (U.S.) and Sandi Pniauskas (Canada), announce the first ever Ovarian Cancer Survivors Debate. The two conferences are survivor-led and survivor-organized with debate and discussion surrounding the multitude of issues - the past and the present. Open and lively dialogue will be encouraged.
WHO SHOULD ATTEND:
All cancer survivors/caregivers, healthcare professionals, researchers, pharmacists and the general public are encouraged to attend and participate.
WHERE/
WHEN:
#1: Sheraton Hotel, Novi, MI Sat. October 27th, 2007
#2: Metropolitan Hotel, Toronto, ON Sat. November 3rd, 2007
Time: 10:00 am - 12:30 pm
No cost to attend
Ovarian cancer has the highest mortality rate of all gynecologic cancers and there is no early detection test. The debate and ensuing open forum public discussions will include the specifics of disease-related issues including genetics, access to care and communications. Carolyn Benivegna is a nine year ovarian cancer survivor, a BRCA1 carrier and Founder/Board Member of OCAG-GC. Sandi Pniauskas is an eight ovarian cancer survivor with a genetic predisposition to Lynch Syndrome/Hereditary NonPolyposis Colorectal Cancer and a member of the Cochrane Collaboration. Ovarian cancer survivors Annamarie DeCarlo and Dr. Yi Pan will co-moderate both events. Bridget Capo (R.N.) and Pamela J. West (R.N.) will provide support and collaborate with Benivegna and Pniauskas in formal publication of the event proceedings.
"Our community is very pleased to offer this exciting open public forum without cost to participants and we encourage active dialogue. We value our professional and family caregivers, but have seen the need, over years, for our community of cancer patients to have open discussions on the real issues that affect their lives. Today, and for the future. We need to appreciate the past, so that we may effectively bring attention to the sufferings experienced in our community. Most importantly we need to escalate change.” Benivegna/Pniauskas
Post a Comment
Survivors' Debate: The Past Decade in Ovarian Cancer
Two Countries-Two Debates: Patient-led/funded:
Ovarian cancer survivors, Carolyn Benivegna (U.S.) and Sandi Pniauskas (Canada), announce the first ever Ovarian Cancer Survivors Debate. The two conferences are survivor-led and survivor-organized with debate and discussion surrounding the multitude of issues - the past and the present. Open and lively dialogue will be encouraged.
WHO SHOULD ATTEND:
All cancer survivors/caregivers, healthcare professionals, researchers, pharmacists and the general public are encouraged to attend and participate.
WHERE/
WHEN:
#1: Sheraton Hotel, Novi, MI Sat. October 27th, 2007
#2: Metropolitan Hotel, Toronto, ON Sat. November 3rd, 2007
Time: 10:00 am - 12:30 pm
No cost to attend
Ovarian cancer has the highest mortality rate of all gynecologic cancers and there is no early detection test. The debate and ensuing open forum public discussions will include the specifics of disease-related issues including genetics, access to care and communications. Carolyn Benivegna is a nine year ovarian cancer survivor, a BRCA1 carrier and Founder/Board Member of OCAG-GC. Sandi Pniauskas is an eight ovarian cancer survivor with a genetic predisposition to Lynch Syndrome/Hereditary NonPolyposis Colorectal Cancer and a member of the Cochrane Collaboration. Ovarian cancer survivors Annamarie DeCarlo and Dr. Yi Pan will co-moderate both events. Bridget Capo (R.N.) and Pamela J. West (R.N.) will provide support and collaborate with Benivegna and Pniauskas in formal publication of the event proceedings.
"Our community is very pleased to offer this exciting open public forum without cost to participants and we encourage active dialogue. We value our professional and family caregivers, but have seen the need, over years, for our community of cancer patients to have open discussions on the real issues that affect their lives. Today, and for the future. We need to appreciate the past, so that we may effectively bring attention to the sufferings experienced in our community. Most importantly we need to escalate change.” Benivegna/Pniauskas
<< Home
